(Q64044005)
Statements
A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS) (English)
0 references
June 2008
0 references
December 2008
0 references
15
0 references
18 year
0 references